Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients.

Source:http://linkedlifedata.com/resource/pubmed/id/14526206

J. Acquir. Immune Defic. Syndr. 2003 Oct 1 34 2 174-83

Download in:

View as

General Info

PMID
14526206